Amyloid enhancing factor and dietary transmission in accelerated amyloid A amyloidosis

Clinical Immunology and Immunopathology

Volumn 88, Issue 1, 1998, Pages 65-69

  Elliott Bryant, Rosemary ^a,b   Cathcart, Edgar S ^a,b  

^a Center for Health Quality Outcomes and Economic Research   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid enhancing factor; Amyloidosis; Dietary transmission

Indexed keywords

AMYLOID A PROTEIN;

AMYLOIDOSIS; ANIMAL TISSUE; ARTICLE; DIETARY INTAKE; DISEASE TRANSMISSION; FEMALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0031856786     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4555     Document Type: Article

References (32)

1. Bolton D. C., McKinley M. P., Prusiner S. B. Identification of a protein that purifies with the scrapie prion. Science. 218:1982;1309-1311.
2. Prusiner S. B., McKinley M. P., Bowman K. A., Bolton D. C., Bendheim P. E., Groth D. F., Glenner G. G. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell. 35:1983;349-358.
3. Glenner G. G. Amyloid deposits and amyloidosis: The β-fibrilloses. N. Engl. J. Med. 302:1980;1283-1292.
4. Glenner G. G. Amyloid deposits and amyloidosis: The β-fibrilloses. N. Engl. J. Med. 302:1980;1333-1343.
5. Beyreuther K., Masters C. L. Catching the culprit prion. Nature. 370:1994;419-420.
6. Hill A. F., Desbruslais M., Joiner S., Sidle K. C. L., Gowland I., Collinge J., Doey L. J., Lantos P. The same prion strain causes vCJF and BSE. Nature. 389:1997;448-450.
7. Bruce M. E., Will R. G., Ironside J. W., McConnell I., Drummond D., Suttie A., McCardle L., Chree A., Hope J., Birkett C., Cousens S., Fraser H., Bostock C. J. Transmission to mice indicate that a 'new varient' CJD is caused by the BSE agent. Nature. 389:1997;498-501.
8. Scott M., Foster D., Mirenda C., Serban D., Courfal F., Walchli M., Torchia M., Groth D., Carlson G., DeArmond S. J., Westaway D., Prusiner S. B. Transgenic mice expressing hamster prion protein produce species specific scrapie infectivity and amyloid plaques. Cell. 59:1989;847-857.
9. Bueler H., Aguzzi A., Sailer A., Greiner R.-A., Autenried P., Aguet M., Weissman C. Mice devoid of PrP are resistant to scrapie. Cell. 73:1993;1339-1347.
10. Prusiner S. B., Groth D., Serban A., Koehler R., Foster D., Torchia M., Burton D., Yang S-L., DeArmond S. J. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc. Natl. Acad. Sci. USA. 90:1993;10608-10612.
11. Telling G. C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F. E., DeArmond S. J., Prusiner S. B. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell. 83:1995;79-90.
12. Cohen A. S., Cathcart E. S. Casein-induced experimental amyloidosis. I. Review of cellular and immunologic aspects. Methods Achiev. Exp. Pathol. 6:1972;207-242.
13. Axelrad M. A., Kisilevsky R. Biological characterization of amyloid enhancing factor. Amyloid and Amyloidosis, Proceedings of the Third symposium on Amyloidosis, Povoa de Vazim, Portugal, 1979. 1980;Exerpta Medica, Amsterdam. p. 527-533.
14. Axelrad M. A., Kisilevsky R., Willmer J., Chen S. J., Skinner M., Cohen A. S. Further characterization of amyloid-enhancing factor. Lab. Invest. 47:1982;139-146.
15. Shirahama T., Lawless O. J., Cohen A. S. Heterologous transfer of amyloid - Human to mouse. Proc. Soc. Exp. Biol. Med. 130:1969;516-519.
16. Varga J., Flinn M. S. M., Shirahama T., Rodgers O. G., Cohen A. S. The induction of accelerated murine amyloid with human splenic extract. Virchows Arch. 51:1986;177-185.
17. Ali-Khan Z., Quirion R., Robitaille Y., Alizadeh-Khiavi K., Du T. Evidence for increased amyloid enhancing factor activity in Alzheimer brain extract. Acta Neuropathol. 77:1988;82-90.
18. Neiwold T. A., Hol P. R., van Andei A. C., Lutz E. T. G., Gruys E. Enhancement of amyloid induction by amyloid fragments in hamster. Lab. Invest. 56:1987;544-549.
19. Gadjusek D. C. Spontaneous generation of infectious nucleating amyloids in transmissible and nontransmissible cerebral amyloidoses. Mol. Neurobiol. 8:1994;1-13.
20. Shirahama T., Miura K., Ju S-T., Kisilevsky R., Gruys E., Cohen A. S. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab. Invest. 1:1990;61-68.
21. Gonnerman W. A., Kandel R., Cathcart E. S. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice. Lab. Invest. 74:1996;259-264.
22. Sipe J. D., Carreras I., Gonnerman W. A., Cathcart E. S., de Beer M. C., de Beer F. C. Characterization of the inbred CE/J mouse strain as amyloid resistant. Am. J. Pathol. 143:1993;1480-1485.
23. Lucke B., Markley L. A. Difference in susceptibility of mice and rats to experimental production of amyloidosis. Proc. Soc. Exp. Biol. Med. 25:1928;642-646.
24. Sipe J. D., Gonnerman W. A., Loose L. D., Knapschaefer G., Xie W-J., Franzblau C. Direct binding solid phase ELISA for serum amyloid A (SAA). J. Immunol. Methods. 125:1989;125-135.
25. Gonnerman W. A., Elliott-Bryant R., Carreras I., Sipe J. D., Cathcart E. S. Linkage of protection against amyloid fibril formation in the mouse to a single autosomal gene. J. Exp. Med. 181:1995;2249-2252.
26. Elliott-Bryant R., Cathcart E. S. Apolipoprotein A-1 knock-out mice readily develop amyloid A amyloidosis. Clin. Immunol. Immunopathol. 85:1997;104-108.
27. Cathcart E. S. AEF: An enigma wrapped in a mystery. Amyloid. 2:1995;126-127.
28. Alizadeh-Khiavi K., Normand J., Chronopoulos S., Ali-Khan Z. Alzheimer's disease brain-derived ubiquitin has amyloid-enhancing factor activity: Behavior of ubiquitin during accelerated amyloidogenesis. Acta Neuropathol. 81:1991;280-286.
29. Ganowiak K., Hultman P., Engstrom U., Gustavsson A., Westermark P. Fibrils from synthetic amyloid related peptides enhance development of experimental AA amyloidosis in mice. Biochem. Biophys. Res. Commun. 199:1994;306-312.
30. Niewold T. H. A., Gruys E., Arakawa T., Shirahama T., Kisilevsky R. Recombinant human tumor necrosis factor-alpha (rhTNF-alpha) and rhTNF-alpha analogue enhance amyloid deposition in the Syrian hamster. Scand. J. Immunol. 37:1993;29-32.
31. Tagouri Y. M., Sanders P. W., Picken M. M., Siegal G. P., Kerby J. D., Herrera G. A. In vitro. Lab. Invest. 74:1996;290-302.
32. Williams R. C., Cathcart E. S., Calkins E., Fite G. L., Rubio J. B., Cohen A. S. Secondary amyloidosis in lepromatous leprosy: Possible relations of diet and environment. Ann. Intern. Med. 62:1965;1000-1007.